Teva, Bayer Settle Dispute Over Levitra Patents
Two Bayer AG units reached a settlement with Teva Pharmaceuticals USA Inc. over two erectile dysfunction patents, ending the five cases Bayer launched to prevent Teva's bid to make a generic...To view the full article, register now.
Already a subscriber? Click here to view full article